40 / 56
40
Educational Seminars
Saturday, 22 April 2017
ES-05
Educational Seminar
16:30–17:30
East Meetingroom 14
Cyber addiction and ADHD as a global new syn-
drome in adolescents
Chair: O. Bilke-Hentsch, Switzerland
Description
Eighty to ninety percent of all children and adolescents
enjoy the use of modern electronic interactive media and
the web 2.0 as well as social networks to enrich their
lives, although parents and teachers sometimes have
got different ideas of meaningful activity. On the other
end of the spectrum pathological Internet and media
use (“PIU”) seems to emerge as an important public
mental health problem in children and adolescents of
risc populations e.g. with ADHD, learning disorders and
social phobia.
After 20 years of clinical and basic research on the
side-effects of inappropriate use the problem has been
partly considered in DSM5 as a disease entity (Internet
gaming disorder) since 2013. Although the concept is
still discussed controversly by addiction therapists, there
exist clinical and neurobiological findings, that PIU and
its severe addiction form resembles classical adolescent
addiction patterns such as gambling, marihuana or
alcohol dependency.
There seems to be a small but severely ill subgroup of
multiple media users with comorbidity and multiple risk
factors that develop pervasive social isolation, increase of
dosage, craving and other features of addiction.
This is important in particular for ADHD patients, because
their core symptoms are excessively rewarded by several
Internet and media applications.
In this seminar recent diagnostic and therapeutic
concepts will be discussed in order to encourage ADHD
therapists to recognize PIU as a major problem in an
increasing subgroup of ADHD patients.
Using the clinical diagnosis group PIU, in the Swiss
Kanton Zuerich a comorbidity-oriented out- and in-
patient approach has been established on a hospital-
based level. Psychoeducation, neuropsychological
diagnosis, counselling of parents and teachers and
treating severe individual cases in a three-step approach
(SOMOSA-Medialab) are some parts of the programme.
ES-06
Educational Seminar
16:30–17:30
Ballroom BC
Diagnostic process and treatment planning for
children
Chairs: M. Stein, USA, I. Manor, Israel
Description
We will review the diagnostic process using several
case example of simple, subtle, and complex ADHD,
and provide a model for providing feedback and linking
diagnostic findings to treatment. Strategies for identifying
symptoms, comorbidities, impairments, comorbidities,
and strengths (SIMMS) will be reviewed as well as
diagnostic dilemmas and controversies, such as limitations
of behavior rating scales, use of laboratory measures, and
the role of psychological/neuropsychological tests.
ES-07
Educational Seminar
16:30–17:30
Ballroom A
ADHD treatment in pregnancy and child outcomes
Chair: D. Silva, Australia
Description
ADHD is being more recognised and treated across the
globe with an understanding that ADHD symptoms do
not just disappear in adolescents but may need regular
treatment into adulthood. There are more females
of childbearing age required to make a decision on
either discontinuing, reducing the dose or continuing
medication to treat their ADHD. The advice of their
doctors and specialists is important and needs to be
delivered with an understanding of all the evidence to
date. Unfortunately, this evidence is limited. The U.S.
Food and Drug Administration has classified ADHD
medications as being "pregnancy category C", implying
that there is insufficient information to confirm either
harm or lack of harm. Mouse studies have shown
the teratogenicity of MPH but not in small human
studies. However, there is evidence of some increase in
miscarriage rates and lower birth weight.
Currently, there are no adequate guidelines for the
treatment of ADHD across pregnancy and in the
postpartum period. This education session will provide
an understanding of the current evidence, suggested
patient management and future studies.
w
Registration fee for Educational Seminars and Meet the Experts, per session: EUR 50.
Only valid in combination with the congress registration fee.